Cargando…
COVID-19, cardiovascular diseases and cardiac troponins
There has been strong evidence of myocardial injury in coronavirus disease 2019 (COVID-19) patients with significantly elevated serum cardiac troponin (cTn). While the exact mechanism of injury is unclear, possible suggested pathological mechanisms of injury are discussed. These include increased su...
Autores principales: | Kim, Chan W, Aronow, Wilbert S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438926/ https://www.ncbi.nlm.nih.gov/pubmed/34476978 http://dx.doi.org/10.2217/fca-2021-0054 |
Ejemplares similares
-
Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
por: Sao, Rahul, et al.
Publicado: (2017) -
Cardiac troponins: from myocardial infarction to chronic disease
por: Park, Kyung Chan, et al.
Publicado: (2017) -
Management of cardiac hemochromatosis
por: Aronow, Wilbert S.
Publicado: (2017) -
Peripheral arterial disease in the elderly
por: Aronow, Wilbert S
Publicado: (2007) -
Clinical utility of cardiac troponin measurement in COVID-19 infection
por: Gaze, David C
Publicado: (2020)